MédiMabs’ mission is to be the most flexible and versatile company to respond to the varied needs of researchers in the field of antibody applications.

Medimabs operates as a specialized Boutique for antibodies.

It collaborates with research laboratories and institutions. It is therefore the ideal partner for R&D projects. MédiMabs provides to researchers high quality research grade monoclonal and polyclonal antibodies. It also offers  extensive services such as de novo generation of antibodies, peptide design and synthesis, and innovative cost effective antibody humanization. It endeavors to deliver unparalleled customer support.

MédiMabs operates as a Boutique for antibodies to offer personalized antibody application support . It is structured to analyze new needs that arise in the research world. To address such needs, MédiMabs can conduct a variety of R&D projects, develops new research tools and provide antibodies and related services for which there is a high demand.

Thanks to their vast experience and numerous connections to the investigation community in varied areas, the founders of MédiMabs have direct access to the newly-generated antibodies in research laboratories worldwide. Their involvement in the pharmaceutical and biotechnology sphere further enhances and facilitates the acquisition of licenses from the governing technology offices of the different research institutions.

Their hands-on use of antibodies in their own research activities allows them to better address issues involved in their own genomic and protemic projects as well as to resolve customer dissatisfaction such as lack of product availability, lack of selection, paucity of references, paucity of high quality application-specific notes. They are equipped to provide pertinent advice in the design of research projects involving antibody research.

MédiMabs offers the most competitive royalty-based compensation package for the licensing of research generated antibodies. Through key international partnerships it is able to facilitate the process of antibody drug discovery. It offers very innovative and cost effective humanization services.

•    In-depth theoretical and applied scientific knowledge of the antibody field
•    Vast experience in the research area, thus thorough  understanding of research tools
required in the biomedical sector
•    Extensive expertise in the successful management of research and commercial operations
•    Distinguished reputations and acquired credibility among potential customers

De Novo Generated Antibodies

MédiMabs produces and licenses de novo generated antibodies.

All licenses are acquired on royalty compensation basis. A special additional royalty payment is allocated for ongoing involvement on the part of the inventor in MédiMabs’customer service process. MédiMabs offers source providers the most rewarding, innovative, and quickest licensing agreements in the industry.

De novo Monoclonal  and Polyclonal Antibody Production

Option A - Fee For Service

MédiMabs offers high quality service for antibody production. In  four months, MédiMabs can generate ELISA-positive monoclonal antibodies from synthetic peptides, phospho-peptides or recombinant proteins.

MédiMabs works closely with researchers in order to deliver the highest possible quality products. Our options include parallel testing of positive clones with the researcher’s lab. This allows researchers to select clones suitable for specific applications at an early stage. MédiMabs’ team of scientific professionals will work with you throughout the entire process of peptide design and synthesis.

Option B - Research and Development

MédiMabs offers the option of producing custom monoclonal antibodies under the concept of shared intellectual property rights.

Commercialization

The company has contracted Medicorp, a well recognized international research-grade-reagent distributing company, to conduct Canadian sales and distribution of its antibodies. United States and European sales and distribution are conducted by Medimabs and his distributors.

Distribution

MédiMabs serves as a global distributor for pre-existing monoclonal antibody catalogs.